EnteroTarget ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  30.9% 18.3% 16.1% 4.2% 1.8%  
Credit score (0-100)  1 8 10 48 70  
Credit rating  C B BB BBB A  
Credit limit (kDKK)  0.0 0.0 -0.0 0.0 0.3  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  -19.8 60.3 -338 35.7 100  
EBITDA  -19.8 60.3 -338 25.7 72.2  
EBIT  -19.8 60.3 -338 25.7 72.2  
Pre-tax profit (PTP)  -19.8 60.1 -344.1 -6.8 43.2  
Net earnings  -15.5 46.9 -268.4 -6.8 282.0  
Pre-tax profit without non-rec. items  -19.8 60.1 -344 -6.8 43.2  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  205 252 -16.8 460 742  
Interest-bearing liabilities  0.0 0.0 304 492 776  
Balance sheet total (assets)  211 362 297 974 1,540  

Net Debt  -166 -329 129 298 734  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -19.8 60.3 -338 35.7 100  
Gross profit growth  49.7% 0.0% 0.0% 0.0% 180.4%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  211 362 297 974 1,540  
Balance sheet change%  702.9% 71.7% -17.9% 227.7% 58.1%  
Added value  -19.8 60.3 -338.3 25.7 72.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 373 756  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -2.0 1.0 -1.0 1.0 2.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 72.0% 72.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -16.7% 21.1% -100.1% 4.0% 5.7%  
ROI %  -17.6% 26.4% -121.8% 4.1% 5.8%  
ROE %  -13.7% 20.5% -97.8% -1.8% 46.9%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  97.2% 69.5% -5.3% 47.3% 48.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  835.1% -545.4% -38.2% 1,157.0% 1,016.3%  
Gearing %  0.0% 0.0% -1,813.9% 106.8% 104.5%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 3.8% 8.2% 4.6%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  35.1 3.3 0.9 1.2 0.5  
Current Ratio  35.1 3.3 0.9 1.2 0.5  
Cash and cash equivalent  165.6 329.0 174.8 193.9 42.4  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  204.8 251.7 -16.8 87.7 -386.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0